Paul Shattock

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Paul Shattock OBE is a British autism researcher and scientific consultant to the charity Education and Services for People with Autism, of which he is also the founder.[1] He was formerly the director of the Autism Research Unit at the University of Sunderland. He is well known for his disputed research into dietary therapy and autism, having claimed that autistic children may have a "leaky gut" which allows certain peptides to enter the bloodstream, and claimed that they excrete unusually high levels thereof. As a result of this speculation, he has promoted the use of a gluten-free, casein-free diet to ameliorate the symptoms of autism, a theory he developed along with Kalle Reichelt. In addition, he has claimed that a protein found in milk may play a role in the etiology of autism.[2] He is also the former president of the World Autism Organization.

In 2002, Shattock conducted a survey and claimed that this survey had identified a unique subset of autistic children who may be uniquely susceptible to the MMR vaccine. These children were identified by the fact that they tended to suffer from bowel problems, had an abnormal gait and were friendlier than other autistic children.[3] In addition, this survey concluded that one in ten parents of autistic children attributed their child's autism to this vaccine, and that these children had much higher levels of urinary indolyl-3-acryloylglycine.[4][5] However, Shattock was criticized by Peter Dukes of the Medical Research Council, who noted that Shattock's findings had yet to be published in a peer-reviewed journal.[6]

Personal life[edit]

Shattock has a son, Jamie, who was diagnosed with autism in 1975.[7]


  1. ^ Nelson, Barry (4 February 2010). "Consultant to the Espa Autism Research Unit". The Northern Echo. Retrieved 9 June 2017.
  2. ^ "The World Today - Autism, milk link played down". 2002-11-13. Retrieved 2013-10-10.
  3. ^ Derbyshire, David (2002-06-28). "MMR 'may be linked to certain type of autism'". Telegraph. Retrieved 2013-10-10.
  4. ^ Anderson, R. J.; Bendell, D. J.; Garnett, I.; Groundwater, P. W.; Lough, W. J.; Mills, M. J.; Savery, D.; Shattock, P. E. G. (2002). "Identification of indolyl-3-acryloylglycine in the urine of people with autism". Journal of Pharmacy and Pharmacology. 54 (2): 295–298. doi:10.1211/0022357021778349. PMID 11858215.
  5. ^ Fitzpatrick, Michael (17 July 2007). "The dark art of the MMR-autism panic". Spiked. Retrieved 30 January 2014.
  6. ^ Meikle, James (28 June 2002). "MMR 'may cause 1 in 10 cases of autism'". The Guardian. Retrieved 10 October 2013.
  7. ^ Shattock, Paul; Todd, Linda. "Sunderland University & The Autism Research Unit: The Early Years". Retrieved 10 October 2013.